Sherman M - Search Results

1

Health state utilities and quality of life in patients with hepatitis B.

Woo G, Tomlinson G, Yim C, Lilly L, Therapondos G, Wong DK, Ungar WJ, Einarson TR, Sherman M, Heathcote JE, Krahn M. Woo G, et al. Among authors: sherman m. Can J Gastroenterol. 2012 Jul;26(7):445-51. doi: 10.1155/2012/736452. Can J Gastroenterol. 2012. PMID: 22803020 Free PMC article.

2

Health-state utilities and quality of life in hepatitis C patients.

Chong CA, Gulamhussein A, Heathcote EJ, Lilly L, Sherman M, Naglie G, Krahn M. Chong CA, et al. Among authors: sherman m. Am J Gastroenterol. 2003 Mar;98(3):630-8. doi: 10.1111/j.1572-0241.2003.07332.x. Am J Gastroenterol. 2003. PMID: 12650799

3

Clinical recommendations for the use of recombinant human erythropoietin in patients with hepatitis C virus being treated with ribavirin.

Sherman M, Cohen L, Cooper MA, Elkashab M, Feinman V, Fletcher D, Girgrah N, Heathcote J, Levstik M, McNaull WB, Wong D, Wong F, Yim C. Sherman M, et al. Can J Gastroenterol. 2006 Jul;20(7):479-85. doi: 10.1155/2006/497059. Can J Gastroenterol. 2006. PMID: 16858501 Free PMC article. Review.

4

Management of solitary 1 cm to 2 cm liver nodules in patients with compensated cirrhosis: a decision analysis.

Bremner KE, Bayoumi AM, Sherman M, Krahn MD. Bremner KE, et al. Among authors: sherman m. Can J Gastroenterol. 2007 Aug;21(8):491-500. doi: 10.1155/2007/182383. Can J Gastroenterol. 2007. PMID: 17703248 Free PMC article. Review.

5

Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses.

Woo G, Tomlinson G, Nishikawa Y, Kowgier M, Sherman M, Wong DK, Pham B, Ungar WJ, Einarson TR, Heathcote EJ, Krahn M. Woo G, et al. Among authors: sherman m. Gastroenterology. 2010 Oct;139(4):1218-29. doi: 10.1053/j.gastro.2010.06.042. Epub 2010 Jun 20. Gastroenterology. 2010. PMID: 20600036 Review.

6

Interferon alfa treatment of chronic hepatitis B: randomized trial in a predominantly homosexual male population.

Wong DK, Yim C, Naylor CD, Chen E, Sherman M, Vas S, Wanless IR, Read S, Li H, Heathcote EJ. Wong DK, et al. Among authors: sherman m. Gastroenterology. 1995 Jan;108(1):165-71. doi: 10.1016/0016-5085(95)90021-7. Gastroenterology. 1995. PMID: 7806038 Clinical Trial.

7

HIV-positive patients with nonalcoholic fatty liver disease have a lower body mass index and are more physically active than HIV-negative patients.

Mohammed SS, Aghdassi E, Salit IE, Avand G, Sherman M, Guindi M, Heathcote JE, Allard JP. Mohammed SS, et al. Among authors: sherman m. J Acquir Immune Defic Syndr. 2007 Aug 1;45(4):432-8. doi: 10.1097/QAI.0b013e318074efe3. J Acquir Immune Defic Syndr. 2007. PMID: 17558337

8

Management of chronic hepatitis B: consensus guidelines.

Sherman M, Shafran S, Burak K, Doucette K, Wong W, Girgrah N, Yoshida E, Renner E, Wong P, Deschênes M. Sherman M, et al. Can J Gastroenterol. 2007 Jun;21 Suppl C(Suppl C):5C-24C. Can J Gastroenterol. 2007. PMID: 17568823 Free PMC article.

9

Management of chronic hepatitis C: consensus guidelines.

Sherman M, Shafran S, Burak K, Doucette K, Wong W, Girgrah N, Yoshida E, Renner E, Wong P, Deschênes M. Sherman M, et al. Can J Gastroenterol. 2007 Jun;21 Suppl C(Suppl C):25C-34C. Can J Gastroenterol. 2007. PMID: 17568824 Free PMC article.

10

The management of chronic viral hepatitis: a Canadian consensus conference 2004.

Sherman M, Bain V, Villeneuve JP, Myers RP, Cooper C, Martin S, Lowe C. Sherman M, et al. Can J Gastroenterol. 2004 Dec;18(12):715-28. doi: 10.1155/2004/201031. Can J Gastroenterol. 2004. PMID: 15605136 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,491 results

Search Page